• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

由O139群霍乱弧菌引起的临床霍乱中的血清抗菌和抗毒素反应及其在保护作用中的重要性评估

Serum antibacterial and antitoxin responses in clinical cholera caused by Vibrio cholerae O139 Bengal and evaluation of their importance in protection.

作者信息

Nandy R K, Albert M J, Ghose A C

机构信息

Department of Microbiology, Bose Institute, Calcutta, India.

出版信息

Vaccine. 1996 Aug;14(12):1137-42. doi: 10.1016/0264-410x(96)00035-7.

DOI:10.1016/0264-410x(96)00035-7
PMID:8911010
Abstract

Vibrio cholerae O139 Bengal strain was the causative agent of the recent epidemics of cholera in India and Bangladesh. We studied antibacterial and antitoxin immune responses in acute and convalescent phase paired sera collected from seven of these cholera patients. Significant rise in the levels of both antibacterial and antitoxin antibodies was demonstrable in the sera of convalescent cholera patients. Antibacterial antibodies, directed primarily against O139 lipopolysaccharides (LPS), belonged to IgM class, while antitoxin antibodies were of IgG and IgA class and neutralized cholera toxin. The convalescent sera, however, showed no increase in the reactivity towards V. cholerae O1 whole cells or their LPS preparation. Immunoblotting experiments revealed that the convalescent, but not the acute, phase serum recognized the truncated form of LPS characteristics of O139 strains. Convalescent serum also induced definite protection against O139, but not O1, challenge in experimental animal model. Further studies showed that such protection was probably mediated by antibodies inhibiting intestinal colonization of O139 organisms. These results suggest that critical difference(s) exists between the immunogenic somatic components of V. cholerae O1 and O139 organisms that are of considerable importance in protection against cholera.

摘要

霍乱弧菌O139孟加拉菌株是近期印度和孟加拉国霍乱流行的病原体。我们研究了从其中7名霍乱患者采集的急性期和恢复期配对血清中的抗菌和抗毒素免疫反应。恢复期霍乱患者血清中抗菌和抗毒素抗体水平均有显著升高。主要针对O139脂多糖(LPS)的抗菌抗体属于IgM类,而抗毒素抗体属于IgG和IgA类,并能中和霍乱毒素。然而,恢复期血清对霍乱弧菌O1全细胞或其LPS制剂的反应性没有增加。免疫印迹实验表明,恢复期血清而非急性期血清能识别O139菌株特有的截短形式的LPS。恢复期血清在实验动物模型中也能诱导对O139而非O1攻击的明确保护作用。进一步研究表明,这种保护作用可能是由抑制O139菌在肠道定植的抗体介导的。这些结果表明,霍乱弧菌O1和O139菌的免疫原性菌体成分之间存在关键差异,这在预防霍乱方面具有相当重要的意义。

相似文献

1
Serum antibacterial and antitoxin responses in clinical cholera caused by Vibrio cholerae O139 Bengal and evaluation of their importance in protection.由O139群霍乱弧菌引起的临床霍乱中的血清抗菌和抗毒素反应及其在保护作用中的重要性评估
Vaccine. 1996 Aug;14(12):1137-42. doi: 10.1016/0264-410x(96)00035-7.
2
Comparison of the vibriocidal antibody response in cholera due to Vibrio cholerae O139 Bengal with the response in cholera due to Vibrio cholerae O1.比较由霍乱弧菌O139孟加拉型引起的霍乱与由霍乱弧菌O1引起的霍乱中杀弧菌抗体反应。
Clin Diagn Lab Immunol. 1995 Nov;2(6):685-8. doi: 10.1128/cdli.2.6.685-688.1995.
3
Intestinal and systemic immune responses in humans after oral immunization with a bivalent B subunit-O1/O139 whole cell cholera vaccine.用二价B亚单位-O1/O139全细胞霍乱疫苗口服免疫后人体的肠道和全身免疫反应
Vaccine. 1996 Oct;14(15):1459-65. doi: 10.1016/s0264-410x(96)00071-0.
4
A comparative study of the properties of Vibrio cholerae O139, O1 and other non-O1 strains.霍乱弧菌O139、O1及其他非O1菌株特性的比较研究
J Med Microbiol. 1995 Apr;42(4):251-7. doi: 10.1099/00222615-42-4-251.
5
Comparison of immune responses in patients infected with Vibrio cholerae O139 and O1.感染霍乱弧菌O139和O1患者的免疫反应比较。
Infect Immun. 1997 Sep;65(9):3571-6. doi: 10.1128/iai.65.9.3571-3576.1997.
6
Antibodies to the truncated (short) form of 'O' polysaccharides (TFOP) of Vibrio cholerae O139 lipopolysaccharides protect mice against experimental cholera induced by encapsulated O139 strains and such protection is mediated by inhibition of intestinal colonization of vibrios.霍乱弧菌O139脂多糖截短型(短型)“O”多糖(TFOP)的抗体可保护小鼠免受由包膜O139菌株引起的实验性霍乱,这种保护作用是通过抑制弧菌在肠道的定殖来介导的。
Vaccine. 1999 Jul 16;17(22):2844-52. doi: 10.1016/s0264-410x(99)00097-3.
7
Comparison of O-specific polysaccharide responses in patients following infection with O139 versus vaccination with a bivalent (O1/O139) oral killed cholera vaccine in Bangladesh.孟加拉国感染 O139 血清型与接种二价(O1/O139)口服霍乱死疫苗后患者 O 特异性多糖反应的比较。
mSphere. 2023 Oct 24;8(5):e0025523. doi: 10.1128/msphere.00255-23. Epub 2023 Aug 30.
8
Immunogenicity and protective role of an IgA reactive 31-kDa antigen of Vibrio cholerae O139.霍乱弧菌O139的一种IgA反应性31 kDa抗原的免疫原性及保护作用
J Med Microbiol. 2001 Jun;50(6):489-498. doi: 10.1099/0022-1317-50-6-489.
9
Electrophoretic mobility and immune response of outer membrane proteins of Vibrio cholerae O139.霍乱弧菌O139外膜蛋白的电泳迁移率及免疫反应
FEMS Immunol Med Microbiol. 1996 Sep;15(2-3):143-8. doi: 10.1111/j.1574-695X.1996.tb00065.x.
10
Validation and characterization of a human volunteer challenge model for cholera by using frozen bacteria of the new Vibrio cholerae epidemic serotype, O139.利用新型霍乱弧菌流行血清型O139的冻存菌对霍乱人体志愿者激发模型进行验证与特性分析。
Infect Immun. 1999 Dec;67(12):6346-9. doi: 10.1128/IAI.67.12.6346-6349.1999.

引用本文的文献

1
IgM specific to lipopolysaccharide of Vibrio cholerae is a surrogate antibody isotype responsible for serum vibriocidal activity.针对霍乱弧菌脂多糖的 IgM 是一种替代抗体同种型,负责血清杀弧菌活性。
PLoS One. 2019 Mar 7;14(3):e0213507. doi: 10.1371/journal.pone.0213507. eCollection 2019.
2
Immunogenicity of a bivalent killed thimerosal-free oral cholera vaccine, Euvichol, in an animal model.一种不含硫柳汞的二价口服霍乱灭活疫苗Euvichol在动物模型中的免疫原性。
Clin Exp Vaccine Res. 2018 Jul;7(2):104-110. doi: 10.7774/cevr.2018.7.2.104. Epub 2018 Jul 31.
3
Safety and immunogenicity of a live oral recombinant cholera vaccine VA1.4: a randomized, placebo controlled trial in healthy adults in a cholera endemic area in Kolkata, India.
口服重组霍乱活疫苗VA1.4的安全性和免疫原性:在印度加尔各答霍乱流行地区健康成年人中进行的一项随机、安慰剂对照试验
PLoS One. 2014 Jul 1;9(7):e99381. doi: 10.1371/journal.pone.0099381. eCollection 2014.
4
Immune responses to cholera in children.儿童对霍乱的免疫反应。
Expert Rev Anti Infect Ther. 2012 Apr;10(4):435-44. doi: 10.1586/eri.12.23.
5
Establishment of an adult mouse model for direct evaluation of the efficacy of vaccines against Vibrio cholerae.建立用于直接评估霍乱弧菌疫苗效力的成年小鼠模型。
Infect Immun. 2009 Aug;77(8):3475-84. doi: 10.1128/IAI.01197-08. Epub 2009 May 26.
6
Evaluation of synthetic schemes to prepare immunogenic conjugates of Vibrio cholerae O139 capsular polysaccharide with chicken serum albumin.制备霍乱弧菌O139荚膜多糖与鸡血清白蛋白免疫原性偶联物的合成方案评估。
Glycoconj J. 2000 Jun;17(6):425-33. doi: 10.1023/a:1007164216202.
7
Preparation, immunogenicity, and protective efficacy, in a murine model, of a conjugate vaccine composed of the polysaccharide moiety of the lipopolysaccharide of Vibrio cholerae O139 bound to tetanus toxoid.由霍乱弧菌O139脂多糖的多糖部分与破伤风类毒素结合而成的结合疫苗在小鼠模型中的制备、免疫原性及保护效力
Infect Immun. 2001 May;69(5):3488-93. doi: 10.1128/IAI.69.5.3488-3493.2001.
8
Vibrio cholerae O139 conjugate vaccines: synthesis and immunogenicity of V. cholerae O139 capsular polysaccharide conjugates with recombinant diphtheria toxin mutant in mice.霍乱弧菌O139结合疫苗:霍乱弧菌O139荚膜多糖与重组白喉毒素突变体在小鼠体内的合成及免疫原性
Infect Immun. 2000 Sep;68(9):5037-43. doi: 10.1128/IAI.68.9.5037-5043.2000.
9
Mucosal and systemic immune responses in humans after primary and booster immunizations with orally administered invasive and noninvasive live attenuated bacteria.口服侵袭性和非侵袭性减毒活细菌进行初次免疫和加强免疫后人体的黏膜和全身免疫反应
Infect Immun. 1999 Jul;67(7):3680-5. doi: 10.1128/IAI.67.7.3680-3685.1999.